J&J Q1 Beat Reveals the Unvarnished Truth Behind 63 Years of Dividend Growth Apr 14, 2026 Life Science
Why Institutions Are Turning Bullish on Biohaven—and the Catalyst That Could Unlock Its Value Apr 13, 2026 Life Science
Eli Lilly Writes a Check. AC Immune Surges 15%. Is This Strategy or Spare Change? Apr 7, 2026 Life Science
These Two Healthcare Dividend Stocks Offer a Safe Haven As Tech Stocks Keep Falling Apr 2, 2026 Life Science
This Popular ETF Quietly Boosted Its Healthcare Stake – High-Yield Dividend Stocks Are the New Favorite Mar 31, 2026 Life Science
Viking Therapeutics Approaches Make-or-Break Moment as Key GLP-1 Data Looms Mar 29, 2026 Life Science
High Volatility, High Reward: Two Biotech Stocks for the Risk-Tolerant Investor Mar 26, 2026 Life Science
Eli Lilly’s Weight-Loss Bet Comes With Risk. This ETF Offers a Smarter Alternative Mar 25, 2026 Life Science
